亚洲社会药学

本期目录

2014年, 第9卷, 第3期　刊出日期：2014-09-20 上一期    下一期

Foreign Experience Reference

Select

Sino-British Comparative Study of Healthcare System LIU Xiao-xi;BI Kai-shun 2014 (3):  97-100.  doi: 摘要 ( 429 )   Objective To improve healthcare system framework in China by learning from British experiences. Methods Three aspects were compared and analyzed, including healthcare insurance coverage, fund-raising mode and healthcare payment methods, and enlightenment was given. Results and Conclusion It is suggested that the government should play the leading role in healthcare reform, raise healthcare reimbursement, increase government’s allowance and reform the payment methods. 相关文章 | 计量指标

Select

A Brief Introduction of Indian Drug Quality Supervision System JIN Yu;SHAO Rong 2014 (3):  101-106.  doi: 摘要 ( 441 )   Objective To give a brief introduction of Indian drug quality supervision system, and to provide references for the development of drug quality supervision in China. Methods Indian drug quality supervision system was fully expounded in the following aspects: pre-quality supervision; in-quality supervision and post-quality supervision. Results and Conclusion Indian pharmaceutical industry develops rapidly in recent years and has a well-organized quality control and supervision system, which may provide references for the perfection of drug quality supervision system in China. 相关文章 | 计量指标

Select

Drug Pricing Methods in Sweden and Its Enlightenment GUO Lang;SUN Li-hua 2014 (3):  107-109.  doi: 摘要 ( 496 )   Objective To provide references for drug pricing in China. Methods Regulations and policies on drug pricing and the price control measures in Sweden were expounded. Results and Conclusion The drug price based on the evaluation results of pharmacoeconomics can not only reflect its value comprehensively, but also provide pricing standards for the drugs that come into the market afterwards. 相关文章 | 计量指标

Research on Pharmaceutical Industry

Select

International Practices of OTC Drug Price Managementand Its Enlightenment GUO Ying;DENG Xiao-li;HUANG Zhe 2014 (3):  110-114.  doi: 摘要 ( 385 )   Objective To discuss the international practices of OTC drug price management its enlightenment to China. Methods Literature reviews were conducted and price management status of OTC drugs in some advanced countries were introduced. Results and Conclusion It is suggested that OTC price management should be liberalized gradually and profit control methods can be adopted to perfect the compensation mechanism and supervision. 相关文章 | 计量指标

Select

International Trade Status of Chinese Medicinal Materialsfrom 2000 to 2012 QIAN Yun-xu;ZHANG Zhong-peng;YANG Yue;BI Kai-shun 2014 (3):  115-118.  doi: 摘要 ( 498 )   Objective To study the international trade trend of Chinese medicinal materials. Methods Trade data from 2000 to 2012, such as Chinese medicinal materials’ total international trade volume, prices of export and import, market shares, were analyzed empirically. Results and Conclusion Trade surplus of Chinese medicinal materials continued to expand and China’s competitiveness was growing substantially. The import prices were relatively stable while the export prices rose rapidly. The commodity compositions of export were relatively steady while those of the import were much more diverse. The export market of Chinese medicinal materials was too concentrated. 相关文章 | 计量指标

Select

Diagnostic Reagent Industry in China: SWOT Analysisand Countermeasures BAI Jian;;DAI Juan;LI Ye 2014 (3):  119-123.  doi: 摘要 ( 435 )   Objective To analyze the current situation of diagnostic reagent industry in China and look for a feasible path for the healthy development of diagnostic reagent industry. Methods Literature review was applied and SWOT analysis was conducted to analyze both internal and external factors that influence diagnostic reagent industry development. Accordingly, suggestions were raised. Results and Conclusion Diagnostic reagent industry in China reaps a high profit with fast development and low price advantage; the disadvantages lie in less investment in research and development and lack of funding; opportunities include good policies, improvement of people’s health awareness and optimization of the industrial structure; the impact of foreign business competition, patent protection and a relative increase in costs are the threats. Therefore, China’s enterprises can solve the problems with talents training, brand building and social financing. 相关文章 | 计量指标

Drug R&D

Select

Risk Aversion in New Drug Research and Development Market ZHANG Xing;LIAN Gui-yu;CHEN Yu-wen 2014 (3):  124-127.  doi: 摘要 ( 496 )   Objective To put forward the corresponding measures for risk aversion so as to improve the success ratio of new drug research and development. Methods Literature review was conducted. Results and Conclusion Market risk of new drug research and development mainly include the following aspects: product risk, demand risk, cost risk, competition risk and policy risk. Institutions of new drug research and development need to evaluate the five risks and take measures to reduce market risk of new drug research and development. 相关文章 | 计量指标

Select

The Safety Monitoring System for Drug Clinical Trials BIAN Lei;YANG Yue 2014 (3):  128-131.  doi: 摘要 ( 436 )   Objective To provide an important theoretical guidance and a practical base for standardizing timely and effectively the safety monitoring system of drug clinical trials by learning experiences from foreign mature practices under the trend of globalization for drug clinical research. Methods Framework of foreign drug safety monitoring system was systematically expounded by analyzing the safety reports, assessment reviews and risk control regulations in clinical trials in the ICH, the United States and the EU. Results and Conclusion At present, drug clinical safety monitoring system in China is still at initial stage, yet it can be perfected constantly by learning experiences from foreign countries to guarantee people’s safety in drug use. 相关文章 | 计量指标

Drug Economy

Select

Analysis of Factors Influencing per Capita Healthcare Expenses-- Based on the Empirical Analysis of Principal Component Regression Modeland Regression with ARMA Model FU Shu-yong;SUN Shu-jun 2014 (3):  132-136.  doi: 摘要 ( 462 )   Objective To analyze the factors that influence per capita healthcare expenses in China. Methods Data stability, influential point, linear, autoregressive model, heteroscedasticity were put into principal component regression model and regression with ARMA model. The tests showed parameters were relatively remarkable. Model quality and the short-term forecast effect were good, too. Results and Conclusion It can been seen that these factors such as economic level, urbanization level and aging population are the main factors and they work equally. 相关文章 | 计量指标

Research on Drugstore

Select

Key Factors on Online Pharmacy Management Based on the Analytic Hierarchy Process in China MENG Ling-quan;WU Zhi-ang;FU Shu-yong;ZHOU Ying 2014 (3):  137-142.  doi: 摘要 ( 462 )   Objective To explore the development path for online pharmacy in China. Methods Key factors were selected from the general management factors of online pharmacy on the basis of the analytic hierarchy process. Results and Conclusion There are eight key factors of the online pharmacy management in China, such as setting up the e-commerce transaction platform, maintaining the loyal consumer groups, building an e-commerce operation team, cultivating the enterprise honesty, setting up the medical insurance payment system and formulating the external policy for the online pharmacy development, etc. 相关文章 | 计量指标

Research on Medical Care

Select

Hospital Outpatient Drug Repercussion: Risks and Countermeasures ZHAO Yang;WANG Shu-ling;TANG Xiao-mei;KONG Ling-yu 2014 (3):  143-150.  doi: 摘要 ( 518 )   Objective To raise measures for reducing hospital outpatient drug repercussion in order to prevent the risks. Methods Typical case analysis and statistical analysis were conducted. Results and Conclusion Drug repercussion phenomenon is caused by many factors, such as imperfect hospital facilities, irrational prescriptions, patients’ weak awareness of rational drug use, etc. Therefore, it is suggested some measures should be taken to reduce the risks of outpatient drug repercussion, for example, setting up related rules for drug repercussion, regulating medical practice of doctors, strengthening the publicity, etc. 相关文章 | 计量指标

Select

Evaluation of Subjective Indicators for Medical ConsumablesBased on Fuzzy Group Decision-Making Methods SHI Lan-ping;HUANG Zhe 2014 (3):  151-156.  doi: 摘要 ( 425 )   Objective To provide references for the evaluation of medical consumable’s bidding. Methods Common subjective indicators were listed according to medical consumable’s bidding scheme. Linguistic variables were applied to evaluate subjective indicators, which was expressed by triangular fuzzy numbers. The decision preference was determined through the calculation. Results and Conclusion Currently the evaluation method of medical consumables is still on initial stage. An example is given to exemplify the model feasible and effective. 相关文章 | 计量指标